Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Protein Arginine Methyltransferase 2 (PRMT2) Peptide

PRMT2 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN938128
  • Target See all PRMT2 products
    PRMT2 (Protein Arginine Methyltransferase 2 (PRMT2))
    Peptide Type
    Synthetic
    Origin
    Mammalian
    Source
    • 7
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequence
    ESQGEEPAEC SEAGLLQEGV QPEEFVAIAD YAATDETQLS FLRGEKILIL
    Characteristics
    A synthetic peptide for use as a blocking control in assays to test for specificity of PRMT2 antibody,
    Alternative Names: PRMT2 control peptide, PRMT2 antibody Blocking Peptide, Anti-PRMT2 Blocking Peptide, Protein Arginine Methyltransferase 2 Blocking Peptide, PRMT2, PRMT-2, PRMT 2, PRMT-2 Blocking Peptide, PRMT 2 Blocking Peptide
  • Application Notes
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C long term.
  • Target
    PRMT2 (Protein Arginine Methyltransferase 2 (PRMT2))
    Synonyms
    PRMT2 Peptide, DKFZp459N1919 Peptide, HRMT1L1 Peptide, Hrmt1l1 Peptide, AI504737 Peptide, protein arginine methyltransferase 2 Peptide, protein arginine methyltransferase 2 L homeolog Peptide, protein arginine N-methyltransferase 2 Peptide, PRMT2 Peptide, Prmt2 Peptide, prmt2.L Peptide
    Background
    The protein arginine methyltransferases (PRMTs) include a family of proteins with related putative methyltransferase domains that modify chromatin and regulate cellular transcription. PRMT2 inhibits NF-kappaB-dependent transcription and promotes apoptosis and it exerts this effect by blocking nuclear export of IkappaB-alpha through a leptomycin-sensitive pathway, increasing nuclear IkappaB-alpha and decreasing NF-kappaB DNA binding. PRMT2 also rendered cells susceptible to apoptosis by cytokines or cytotoxic drugs, likely due to its effects on NF-kappaB.
    Molecular Weight
    48 kDa
You are here:
Support